{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:04:48Z","timestamp":1793271888245,"version":"4.5.0"},"reference-count":49,"publisher":"Informa UK Limited","issue":"16","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1080\/14656566.2025.2583318","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:21:50Z","timestamp":1761844910000},"page":"1599-1606","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Remimazolam - drug evaluations: expert opinion on pharmacotherapy"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7805-9821","authenticated-orcid":false,"given":"Sean D","family":"Hartigan","sequence":"first","affiliation":[{"name":"Tallaght University Hospital","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire C","family":"Nestor","sequence":"additional","affiliation":[{"name":"Tallaght University Hospital","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-274X","authenticated-orcid":false,"given":"Michael G","family":"Irwin","sequence":"additional","affiliation":[{"name":"University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867003375335"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198908000-00015"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0672-3"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew126"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16154"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-74806-9_16"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.2334\/josnusd.21-0051"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.22.16631-9"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00111a041"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00512-7"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01299-8"},{"key":"e_1_3_3_13_1","unstructured":"Pastis NJ Yarmus LB Schippers F et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Clinicaltrials.gov. [cited 2025 Feb 6]. [Online]. https:\/\/clinicaltrials.gov\/study\/NCT02296892"},{"key":"e_1_3_3_14_1","unstructured":"Rex DK Bhandari R Desta T et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Clinicaltrials.gov. [cited 2025 6]. [Online]. https:\/\/clinicaltrials.gov\/study\/NCT02290873"},{"key":"e_1_3_3_15_1","unstructured":"Rex DK Bhandari R Lorch DG et al. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Clinicaltrials.gov. [cited 2025 Feb 6]. [Online]. https:\/\/clinicaltrials.gov\/study\/NCT02532647"},{"key":"e_1_3_3_16_1","unstructured":"EMA. [cited 2025 May 6]. [Online]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/byfavo#product-details"},{"key":"e_1_3_3_17_1","unstructured":"UIDEV. Paion. [cited 2025 May 6]. [Online]. Available from: https:\/\/www.paion.com\/newsdetails\/paion-ag-yichang-humanwell-receives-market-approval-for-remimazolam-in-procedural-sedation-in-china"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000267503.85085.c0"},{"key":"e_1_3_3_19_1","unstructured":"PubChem. Remimazolam. [cited 2025 Feb 20]. [Online]. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9867812"},{"key":"e_1_3_3_20_1","unstructured":"U.S. Food and Drug Administration (FDA). ByfavoTM (remimazolam) for injection for intravenous use. [Online]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/212295s000lbl.pdf"},{"issue":"2","key":"e_1_3_3_21_1","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system\u2013mediated effects","volume":"13","author":"Griffin CE","year":"2013","unstructured":"Griffin CE III, Kaye AM, Bueno FR, et al. Benzodiazepine pharmacology and central nervous system\u2013mediated effects. Ochsner J. 2013;13(2):214.","journal-title":"Ochsner J"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823f0c28"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000548"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.08.062"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-209379\/v1"},{"issue":"8","key":"e_1_3_3_26_1","first-page":"4594","article-title":"The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial","volume":"12","author":"Chen S","year":"2020","unstructured":"Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020 Aug;12(8):4594\u20134603.","journal-title":"Am J Transl Res"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15188"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001902"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1409495"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S391147"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i6.1120"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060971"},{"key":"e_1_3_3_33_1","unstructured":"PAION. Paion AG: mundipharma receives market approval for Anerem\u00ae (Remimazolam) in general anesthesia in Japan. [Online]. cited 2025 Feb 3. Available https:\/\/www.paion.com\/fileadmin\/user_upload\/PAIONA200123EN.pdf"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16205"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902065"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S460949"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.24.18426-X"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.4097\/kja.24537"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1298409"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.10.979"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001938"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.14740\/jcs472"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S401969"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6386606"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S381611"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1253738"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01431-5"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199105000-00011"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003103"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200111000-00019"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2583318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:21:12Z","timestamp":1764742872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2583318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,2]]},"references-count":49,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["10.1080\/14656566.2025.2583318"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2583318","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}